YUYANTANG TCM HKEX IPO Application Lapsed, Ranks Nationwide No.1 in Revenue of Custom-made TCM Plasters

NewTimeSpace News: The listing application submitted by Harbin Yuyantang Traditional Chinese Medicine Outpatient Group Co., Ltd. to HKEX on 16 January 2026 has lapsed following the expiration of the six-month timeline. CMB International and Guoyuan International served as the original joint sponsors.

The Company is a leading private TCM healthcare service provider in China with solid and established presence across Northern China. It adopts a full-life-cycle diagnosis and treatment model integrating medical consultation and prescribed herbal medicines into continuous treatment programmes. Its operation centres on the framework ofoffline initial consultation + online follow-up consultation. All initial consultations are conducted at self-owned, licensed offline medical institutions, while its proprietary online platform supports follow-up visits and chronic disease management to deliver consistent and convenient patient experience. The customer repeat purchase rate reached 81.1% for the nine months ended 30 September 2025.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.